Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Sustained high cortisol production shifts adrenal output away from DHEA.

Chronic HPA axis activation leads to prioritized cortisol synthesis and a relative reduction in adrenal DHEA production.

SupportedJune 19, 202612 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Higher cortisol output can downshift adrenal androgen production (including DHEA) because cortisol and DHEA share upstream steroidogenic steps and ACTH-driven adrenal signaling can favor glucocorticoid production over androgens under sustained demand.

laying out figure…
All 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes an adrenal 'shunting' mechanism where shared steroid precursors are redirected to glucocorticoid synthesis under sustained ACTH demand. Mechanistically, reduced 17,20-lyase efficiency—linked to lower cytochrome b5 activity and altered enzyme partitioning—limits DHEA formation while maintaining cortisol output, raising the cortisol-to-DHEA ratio.

Verified conclusion

Adrenal steroidogenesis is a dynamic process where hormonal output is prioritized based on physiological demand. Research indicates that chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis can lead to a significant shift in adrenal output, favoring life-sustaining glucocorticoids over androgens.

Clinical evidence and outcomes

Chronic stress patterns and HPA axis overactivation consistently demonstrate an elevated cortisol-to-DHEA ratio (CDR), a clinical biomarker for adrenal dysregulation. While acute stress models may show a transient rise in both hormones, sustained demands result in a relative blunting or decrease in DHEA and DHEA-S levels. Kinetic studies of adrenal output show that this "downshift" ensures cortisol production remains prioritized even as androgenic precursors are depleted or diverted.

Mechanistic explanations

The competition between cortisol and DHEA is rooted in their shared synthetic pathways:

  • Shared Precursors: Both hormones originate from cholesterol, which is converted to pregnenolone via the enzyme CYP11A1. Both then utilize the dual-function enzyme CYP17A1 for the initial 17α-hydroxylation step, creating the shared intermediate 17α-hydroxypregnenolone.
  • Enzymatic Partitioning: The divergence occurs at the rate-limiting 17,20-lyase reaction, which is required for DHEA synthesis but is bypassed in the cortisol pathway. Under sustained ACTH drive, the adrenal cortex favors the conversion of 17α-hydroxypregnenolone into the glucocorticoid pathway via 3β-HSD and 21-hydroxylase.
  • Cofactor Regulation: The 17,20-lyase activity of CYP17A1 is dependent on allosteric stimulation by cytochrome b5. Evidence suggests that while acute ACTH may stimulate this process, chronic ACTH exposure can downregulate cytochrome b5 levels and its serine phosphorylation, effectively throttling DHEA output while maintaining the hydroxylase activity necessary for cortisol precursors.

Bottom line

The evidence strongly supports the claim that higher sustained cortisol output downshifts DHEA production. This occurs through "adrenal shunting," where shared precursors are redirected to the glucocorticoid pathway by limiting the 17,20-lyase efficiency required for androgen synthesis.

References

  1. Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17* — jbc.org ↗
  2. The developmental increase in adrenocortical 17,20-lyase activity (biochemical adrenarche) is driven primarily by increasing cytochrome b5 in neonatal rhesus macaques. — pmc.ncbi.nlm.nih.gov ↗
  3. Phosphorylation of Human Cytochrome P450c17 by p38α Selectively Increases 17,20 Lyase Activity and Androgen Biosynthesis* — linkinghub.elsevier.com ↗
  4. Successful Pregnancy in Isolated 17,20-lyase Deficiency Without Glucocorticoid Use or Assisted Reproduction Techniques. — academic.oup.com ↗
  5. Profiling of adrenal corticosteroids in blood and local tissues of mice during chronic stress — pmc.ncbi.nlm.nih.gov ↗
  6. Impaired 17,20-Lyase Activity in Male Mice Lacking Cytochrome b5 in Leydig Cells — academic.oup.com ↗
  7. Structural insights into the function of steroidogenic cytochrome P450 17A1 — pmc.ncbi.nlm.nih.gov ↗
  8. 12515 Single-Nuclei Multiome Analysis Of The Adrenal Gland Identifies Putative Novel Regulators Of Zone-Specific Steroidogenesis — academic.oup.com ↗
  9. Steroidogenic cytochrome P450 17A1 structure and function — pmc.ncbi.nlm.nih.gov ↗
  10. Active site proton delivery and the lyase activity of human CYP17A1. — pmc.ncbi.nlm.nih.gov ↗
  11. Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1 — pmc.ncbi.nlm.nih.gov ↗
  12. Adrenocorticotropin Acutely Regulates Pregnenolone Sulfate Production by the Human Adrenal In Vivo and In Vitro — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→